What is in this leaflet
This leaflet answers some common questions about Serepax. It does not contain all of the available information.
It does not take the place of talking to your doctor or pharmacist.
All medicines have risks and benefits. Your doctor has weighed the risks of you taking Serepax against the benefits they expect it will have for you.
If you have any concerns about taking this medicine, ask your doctor or pharmacist.
Keep this leaflet with the medicine.You may need to read it again.
What it looks like
Serepax tablets are available in 2 strengths.
- Serepax 15 - white, round tablets, one face convex marked "15" and the opposite face flat with Ezi-split breakline.
- Serepax 30 - orange, round tablets, one face convex marked "30" and the opposite face flat with Ezi-split breakline.
Each pack contains 25 tablets.
The active ingredient in SEREPAX tablets is oxazepam.
Each SEREPAX 15 mg tablet contains 15mg oxazepam.
Each SEREPAX 30 mg tablet contains 30mg oxazepam.
SEREPAX 15 mg also contains the following excipients: magnesium stearate, microcrystalline cellulose, polacrilin potassium and lactose.
SEREPAX 30 mg also contains the following excipients: magnesium stearate, methyl cellulose, polacrilin potassium and lactose.
SEREPAX 30 mg also contains Sunset Yellow CI 15985 as a colouring agent.
SEREPAX does not contain gluten, sucrose, tartrazine or any other azo dyes.
SEREPAX is supplied in Australia by:
Sigma Pharmaceuticals (Australia) Pty Ltd 96 Merrindale Drive Croydon Vic 3136 Tel: 03 - 9839 2800
Australian Registration Numbers:
SEREPAX 15 - AUST R 174675 SEREPAX 30 - AUST R 10417
This leaflet was prepared on 13 March 2001 and updated on 11 November 2010.
® Registered Trade Mark